STOCK TITAN

Kratos Defense (KTOS) CEO DeMarco sells 300,000 shares via 10b5-1 plan

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Kratos Defense & Security Solutions, Inc. President & CEO Eric M. DeMarco reported indirect sales by trust of a total of 300,000 shares of common stock on August 14, 2026, in multiple open-market transactions at weighted average prices in the low-to-mid $60s per share. These trades were effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026 and modified on May 15, 2026. As of August 14, 2026, he also had 761,632 shares (indirect) and 63,036 shares (direct) reported as owned, plus 745,000 vested deferred RSUs and 750,000 unvested RSUs that each represent a contingent right to receive one share of common stock.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider DEMARCO ERIC M
Role President & CEO
Sold 300,000 shs ($19.30M)
Type Security Shares Price Value
Sale Common Stock F1, F2 19,638 $63.3317 $1.24M
Sale Common Stock F1, F3 266,316 $64.3321 $17.13M
Sale Common Stock F1, F4 4,946 $65.0538 $322K
Sale Common Stock F1, F5, F6 9,100 $66.1729 $602K
holding Common Stock F6, F7 -- -- --
Holdings After Transaction: Common Stock — 761,632 shares (Indirect, by trust); Common Stock — 63,036 shares (Direct)
Footnotes (7)
  1. F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 6, 2026 and modified on May 15, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.77 to $63.76 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  3. F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.77 to $64.76 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  4. F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.77 to $65.68 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  5. F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.88 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  6. F6. In addition to the 761,632 shares and 63,036 shares reported in Column 5, as of August 14, 2026, 745,000 deferred restricted stock units (RSUs) granted to Mr. DeMarco, representing non-qualified deferred compensation, have vested but remain subject to a previously agreed to 5-year deferral period before issuance and release, which substantially all subject RSUs are scheduled to be released by January 2029, and an additional 750,000 RSUs granted to Mr. DeMarco are currently unvested and will only vest upon achievement of applicable vesting terms described in our proxy statement on Schedule 14A filed with the SEC on April 2, 2026. Each RSU represents a contingent right to receive one share of the Company's common stock.
  7. F7. Includes 43,925 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 19,111 shares held through Issuer's 401(k) Plan.
Total shares sold 300,000 shares Indirect sales by trust of common stock on August 14, 2026
Tranche 1 sale 19,638 shares at $63.3317 Open-market sale of common stock, indirect by trust
Tranche 2 sale 266,316 shares at $64.3321 Open-market sale of common stock, indirect by trust
Tranche 3 sale 4,946 shares at $65.0538 Open-market sale of common stock, indirect by trust
Tranche 4 sale 9,100 shares at $66.1729 Open-market sale of common stock, indirect by trust
Indirect shares owned 761,632 shares Reported as owned in addition to sales as of August 14, 2026
Direct shares owned 63,036 shares Post-transaction direct ownership as of August 14, 2026
RSUs vested and deferred 745,000 RSUs Vested deferred RSUs subject to 5-year deferral period before release
Unvested RSUs 750,000 RSUs Unvested RSUs vesting upon achievement of performance/vesting terms
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
deferred restricted stock units financial
"745,000 deferred restricted stock units (RSUs) granted to Mr. DeMarco"
Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.
non-qualified deferred compensation financial
"representing non-qualified deferred compensation, have vested but remain subject"
Non-qualified deferred compensation is an employer’s promise to pay an employee part of their pay or bonus at a later date, like an IOU that delays taxes until the money is paid out. It matters to investors because these promises create future cash obligations and incentive effects for executives, and unlike standard retirement plans they are not protected in bankruptcy, so they can affect a company’s reported liabilities, cash flow and risk profile.
Employee Stock Purchase Plan financial
"Includes 43,925 shares purchased through Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

What insider transactions did KTOS CEO Eric DeMarco report on this Form 4?

Eric DeMarco reported sales of 300,000 KTOS common shares on August 14, 2026 via a trust. The shares were sold in multiple open-market trades at weighted average prices in the low-to-mid $60s per share, as detailed in the filing footnotes.

Were the KTOS insider sales by Eric DeMarco under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on March 6, 2026 and modified on May 15, 2026. Such plans pre-arrange trades, reducing the significance of trade timing as an information signal.

How many KTOS shares did Eric DeMarco sell and at what prices?

He sold 300,000 shares of KTOS common stock in four tranches: 19,638 shares at $63.3317, 266,316 at $64.3321, 4,946 at $65.0538, and 9,100 at $66.1729. Footnotes note weighted average prices across price ranges from $62.77 to $66.88.

What are Eric DeMarco’s remaining KTOS share holdings after these transactions?

As of August 14, 2026, the filing reports 761,632 shares plus 63,036 shares owned, in addition to the reported sales. These include direct holdings and indirect holdings by trust, as well as shares accumulated through an ESPP and 401(k) plan.

How are Eric DeMarco’s KTOS shares held according to this Form 4?

The reported sales were from shares held indirectly by trust. The filing also notes direct ownership of 63,036 shares, including 43,925 shares via the Employee Stock Purchase Plan and approximately 19,111 shares through the company 401(k) plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DEMARCO ERIC M

(Last)(First)(Middle)
10680 TREENA STREET, SUITE 600

(Street)
SAN DIEGO CALIFORNIA 92131

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
KRATOS DEFENSE & SECURITY SOLUTIONS, INC. [ KTOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026S19,638(1)D$63.3317(2)1,041,994Iby trust
Common Stock08/14/2026S266,316(1)D$64.3321(3)775,678Iby trust
Common Stock08/14/2026S4,946(1)D$65.0538(4)770,732Iby trust
Common Stock08/14/2026S9,100(1)D$66.1729(5)761,632(6)Iby trust
Common Stock63,036(6)(7)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 6, 2026 and modified on May 15, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.77 to $63.76 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.77 to $64.76 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.77 to $65.68 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.88 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
6. In addition to the 761,632 shares and 63,036 shares reported in Column 5, as of August 14, 2026, 745,000 deferred restricted stock units (RSUs) granted to Mr. DeMarco, representing non-qualified deferred compensation, have vested but remain subject to a previously agreed to 5-year deferral period before issuance and release, which substantially all subject RSUs are scheduled to be released by January 2029, and an additional 750,000 RSUs granted to Mr. DeMarco are currently unvested and will only vest upon achievement of applicable vesting terms described in our proxy statement on Schedule 14A filed with the SEC on April 2, 2026. Each RSU represents a contingent right to receive one share of the Company's common stock.
7. Includes 43,925 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 19,111 shares held through Issuer's 401(k) Plan.
Eric M. DeMarco, by Eva Yee, Attorney-In-Fact08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)